Enliven Therapeutics (NASDAQ:ELVN) Trading Down 7.6% on Disappointing Earnings
Enliven Therapeutics, Inc. (NASDAQ:ELVN – Get Free Report) dropped 7.6% on Thursday following a dissappointing earnings announcement. The company traded as low as $18.05 and last traded at $18.38. Approximately 213,862 shares traded hands during trading, a decline of 22% from the average daily volume of 273,690 shares. The stock had previously closed at $19.89. […]
